Clinical Perspectives on KRAS-Mutant NSCLC

/ Clinical Perspectives on KRAS-Mutant NSCLC

Unresectable Locally Advanced KRAS-Mutant NSCLC

This is Part 3 of Clinical Perspectives on KRAS-Mutant NSCLC, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. In this video, Drs. Gregory Riely, Reb...

lung cancer

/ Clinical Perspectives on KRAS-Mutant NSCLC

Second-Line Treatment of KRAS-Mutant Metastatic NSCLC

This is Part 2 of Clinical Perspectives on KRAS-Mutant NSCLC, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. In this video, Drs. Gregory Riely, Reb...

lung cancer

/ Clinical Perspectives on KRAS-Mutant NSCLC

First-Line Treatment of KRAS-Mutant NSCLC

This is Part 1 of Clinical Perspectives on KRAS-Mutant NSCLC, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. In this video, Drs. Gregory Riely, Reb...

Dec

Today In Oncology

Clinical Perspectives on KRAS-Mutant NSCLC

Unresectable Locally Advanced KRAS-Mutant NSCLC

Second-Line Treatment of KRAS-Mutant Metastatic NSCLC

First-Line Treatment of KRAS-Mutant NSCLC

Study Finds Daratumumab Monotherapy Prevented or Delayed Progression From Smoldering to Active Multiple Myeloma

Study Finds Genetic Changes, Elevated Leukemia Risk in Ground Zero First Responders

MRI First Strategy May Be Safe for Prostate Cancer Detection

Addition of SBRT to Systemic Therapy May Improve Outcomes in Select Patients With Locally Advanced Hepatocellular Carcinoma

Epcoritamab Monotherapy for Pretreated Relapsed or Refractory CLL